Status:
ACTIVE_NOT_RECRUITING
Evaluation of Lifestyle Modification on Cardiovascular Risk
Lead Sponsor:
Swansea University
Conditions:
Metabolic Syndrome
Menopause
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
This study proposes to examine the independent and combined effects of an 8-week home-based, equipment-free HIIT exercise intervention with/without Mediterranean diet through ghrelin-mediated alterati...
Detailed Description
This is a randomised-controlled study investigating the independent and combined effects of a home-based, equipment-free high intensity interval training (HIIT) exercise intervention with/without the ...
Eligibility Criteria
Inclusion
- Female
- Participants \>45-65 years of age
- Body mass index (BMI) \>25.0 - 35.0
- Postmenopausal (with spontaneous amenorrhea for the last 12 months)
- Healthy (no known diseases)
- Physically inactive (IPAQ score - category I and not engaged in at least 60 min/week of structured exercise during the previous 6 months)
- Generally well enough to exercise.
Exclusion
- Any inclusion criteria not met
- Abnormal ECG
- Current smokers
- Current or history of substance abuse and/or excess alcohol intake
- Cardiovascular disease
- Cancer
- Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome
- Kidney disease
- Liver disease
- Pancreatitis
- On hormone therapy for \<6 months
- Prescribed anti-hypertensive or beta-blocker medication
Key Trial Info
Start Date :
August 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05417698
Start Date
August 15 2022
End Date
August 15 2025
Last Update
December 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swansea University
Swansea, United Kingdom, sa2 8pp